Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Ligand-based Targeted Therapy: A Novel Strategy For Hepatocellular Carcinoma
M. Li, W. Zhang, Birong Wang, Y. Gao, Z. Song, Q. Zheng
Published 2016 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high morbidity and mortality worldwide. Chemotherapy is recommended to patients with intermediate or advanced stage cancer. However, the conventional chemotherapy yields low desired response rates due to multidrug resistance, fast clearance rate, nonspecific delivery, severe side effects, low drug concentration in cancer cells, and so on. Nanoparticle-mediated targeted drug delivery system can surmount the aforementioned obstacles through enhanced permeability and retention effect and active targeting as a novel approach of therapeutics for HCC in recent years. The active targeting is triggered by ligands on the delivery system, which recognize with and internalize into hepatoma cells with high specificity and efficiency. This review focuses on the latest targeted delivery systems for HCC and summarizes the ligands that can enhance the capacity of active targeting, to provide some insight into future research in nanomedicine for HCC.
This paper references
Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Tianyue Jiang (2012)
Specific binding of glycyrrhetinic acid to the rat liver membrane.
M. Negishi (1991)
Expression of iron regulatory genes in a rat model of hepatocellular carcinoma
P. Holmström (2006)
Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer.
J. Chen (2006)
Cancer's molecular sweet tooth and the Warburg effect.
J. Kim (2006)
Antibodyconjugated nanoparticles for biomedical applications
M Arruebo (2009)
Chemopreventive strategies in hepatocellular carcinoma
S. Singh (2014)
Advantages of RGD peptides for directing cell association with biomaterials.
S. Bellis (2011)
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
J. Xu (2007)
Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Liang Han (2010)
Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation.
W. Wei (2010)
Transferrin targeted core - shell
Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
Liyu Chen (2015)
A Target-Specific Oral Formulation of Doxorubicin-Protein Nanoparticles: Efficacy and Safety in Hepatocellular Cancer
Kishore Golla (2013)
Somatostatin and Its Receptor Family
Y. Patel (1999)
The Cell Surface GRP78 Facilitates the Invasion of Hepatocellular Carcinoma Cells
Xiu-Xiu Zhang (2013)
Functionalized magnetic nanoparticles as vehicles for the delivery of the antitumor drug gemcitabine to tumor cells. Physicochemical in vitro evaluation.
J. Viota (2013)
Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.
Xiaodong Wen (2016)
Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapy.
H. Hanaoka (2015)
Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid.
J. C. Vera (1994)
Development and Characterization of Pectinate Micro/Nanoparticles for Gene Delivery
P. Opanasopit (2007)
A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy
J. Gillet (2016)
N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors
C. Zhang (2014)
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy.
Yuee Cai (2016)
Biotinylated methotrexate loaded erythrocytes for enhanced liver uptake. 'A study on the rat'.
P. R. Mishra (2002)
Smart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinoma.
C. Pilapong (2014)
A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy
T. Trinh (2015)
Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
Chittima Managit (2005)
Porous Lactose-Modified Chitosan Scaffold for Liver Tissue Engineering: Influence of Galactose Moieties on Cell Attachment and Mechanical Stability
Birong Wang (2016)
Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
Z. Luo (2014)
Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
Golam Kibria (2011)
Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
O. Mezghrani (2015)
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics
Z. Li (2005)
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
L. Fan (2010)
Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters.
T. Tengchaisri (1998)
Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications
Hsi-Huang Tseng (2009)
Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Fubing Wang (2013)
Targeted and image-guided photodynamic cancer therapy based on organic nanoparticles with aggregation-induced emission characteristics.
Y. Yuan (2014)
A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma.
Jun-Juan Wang (2012)
Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
Wei Chen (2014)
Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.
J. A. Gutierrez (2013)
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier.
De-Qun Wu (2009)
Adenosine A(2b) receptor is highly expressed in human hepatocellular carcinoma.
H. Xiang (2006)
Self-regulated multifunctional collaboration of targeted nanocarriers for enhanced tumor therapy.
H. Gao (2014)
Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
Geng Kou (2008)
Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.
A. Gomaa (2008)
Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.
S. McDougall (2006)
Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
Bindu Thapa (2015)
siRNA‐MEDIATED BCL‐2 AND BCL‐XL GENE SILENCING SENSITIZES HUMAN HEPATOBLASTOMA CELLS TO CHEMOTHERAPEUTIC DRUGS
X. Lei (2007)
A dual-functionally modified chitosan derivative for efficient liver-targeted gene delivery.
B. Xiao (2013)
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
R. Villa (2013)
Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors
Ahmed A H Abdellatif (2016)
Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
K. Klutz (2011)
Identification of FGF receptorbinding peptides for cancer gene therapy
F Maruta (2002)
In Vivo expression of two novel tumor‐associated antigens and their use in immunolocalization of human hepatocellular carcinoma
H. Takahashi (1989)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm (2016)
Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells.
T. Anirudhan (2016)
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Ling Mei (2014)
Monoclonal antibody‐targeted polymeric nanoparticles for cancer therapy – future prospects
S. Goodall (2015)
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy.
J. Zhang (2016)
The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma
Z Xu (2010)
Theranostical nanosystem‐mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma
Y. Guo (2016)
Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy
Stephanie M. Tortorella (2014)
Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
Y. Zou (2014)
Serotonin promotes tumor growth in human hepatocellular cancer
C. Soll (2010)
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.
S. Parveen (2012)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
M. Feng (2013)
Opposing Effects of Retinoic Acid on Cell Growth Result from Alternate Activation of Two Different Nuclear Receptors
T. Schug (2007)
The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma.
Zhenghong Xu (2009)
Acid-triggered core cross-linked nanomicelles for targeted drug delivery and magnetic resonance imaging in liver cancer cells
X. Li (2013)
Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
Jin Hee Maeng (2010)
Molecular structure of low density lipoprotein: current status and future challenges
R. Prassl (2008)
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.
W. Ma (2014)
Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro
D. Moradpour (1995)
Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
J. Chang (2014)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
Bright far-red/near-infrared conjugated polymer nanoparticles for in vivo bioimaging.
D. Ding (2013)
The epidermal growth factor receptor: from development to tumorigenesis.
M. Sibilia (2007)
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours.
G. Russell-Jones (2004)
for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma
T Zhou (2014)
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
C. Verslype (2012)
Multifunctional organic nanoparticles with aggregation-induced emission (AIE) characteristics for targeted photodynamic therapy and RNA interference therapy.
Guorui Jin (2016)
Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
Ling Meng (2012)
Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data
A. Trouet (2004)
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice
M. Wolschek (2002)
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
T. Kim (2004)
Receptor-mediated folate accumulation is regulated by the cellular folate content.
B. Kamen (1986)
Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems.
Qixia Pan (2016)
Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
K. Takara (2012)
Glycosaminoglycan-targeted iron oxide nanoparticles for magnetic resonance imaging of liver carcinoma.
Rui-meng Yang (2014)
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
M. Jinushi (2003)
Improving the Anticancer Efficacy of Laminin Receptor-Specific Therapeutic Ruthenium Nanoparticles (RuBB-Loaded EGCG-RuNPs) via ROS-Dependent Apoptosis in SMMC-7721 Cells.
Yanhui Zhou (2016)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
Albert Lo (2008)
Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment
N. V. Rao (2016)
Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
Wan-Jiang Xue (2016)
Galactosylated poly(2-(2aminoethyoxy)ethoxy)phosphazene/DNA complex nanoparticles: in vitro and in vivo evaluation for gene delivery. Biomacromolecules
Y Yang (2010)
Lactose mediated liver-targeting effect observed by ex vivo imaging technology.
Ping'an Ma (2010)
Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
Cunxian Duan (2011)
Epidermal growth factor, from gene organization to bedside.
F. Zeng (2014)
The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model.
Zhenghong Xu (2010)
Retinoic acid decorated albumin-chitosan nanoparticles for targeted delivery of doxorubicin hydrochloride in hepatocellular carcinoma
J. Varshosaz (2013)
科技期刊稿件处理的精细化管理——《International Journal of Nanomedicine〉〉投稿体会
Aggregation-induced emission: phenomenon, mechanism and applications.
Yuning Hong (2009)
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
A review of glycosylated carriers for drug delivery.
K. Jain (2012)
European Association for the Study of the Liver
M. Dumont (1971)
Design of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imaging.
W. Wang (2012)
Dual-modal MRI contrast agent with aggregation-induced emission characteristic for liver specific imaging with long circulation lifetime.
Y. Chen (2014)
Pectin nanoparticle enhances cytotoxicity of methotrexate against hepG2 cells
Chuda Chittasupho (2013)
A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex.
Vaishali Bagalkot (2009)
Targeted liposomes to deliver DNA to cells expressing 5-HT receptors.
V. Gopal (2011)
Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma.
Cong Zhang (2016)
Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features.
Y. Lee (1983)
MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis.
X. Chenivesse (1993)
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
J. Varshosaz (2015)
Design considerations for nanotherapeutics in oncology.
T. Stylianopoulos (2015)
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
Samuel Legeay (2015)
Molecular structure, binding properties and dynamics of lactoferrin.
E. Baker (2005)
Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies.
E. Kim (2005)
Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
P. Phillips (2007)
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
D. Richardson (1997)
Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78
L. Zhao (2015)
Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.
H. Moon (2014)
Glypicans: proteoglycans with a surprise.
J. Filmus (2001)
Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability.
D. Venturoli (2005)
Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma
Peifeng Liu (2010)
Development of human hepatocellular carcinoma cell-targeted protein cages.
R. Toita (2012)
Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles.
X. Li (2011)
An Efficient Targeted Drug Delivery through Apotransferrin Loaded Nanoparticles
A. D. Krishna (2009)
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
X. Zhang (2016)
Sensitive electrochemical aptamer cytosensor for highly specific detection of cancer cells based on the hybrid nanoelectrocatalysts and enzyme for signal amplification.
Duanping Sun (2016)
Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Y. Li (2015)
The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Nuo Cao (2011)
Passive vs. Active Targeting: An Update of the EPR Role in Drug Delivery to Tumors
Jaydev Upponi (2014)
Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.
L. Li (2016)
Aptamers and their applications in nanomedicine.
Hongguang Sun (2015)
Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system.
U. Gaur (2000)
Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Xin Li (2013)
Emerging roles of FGF signaling in hepatocellular carcinoma.
Nana Zheng (2016)
Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.
H. Tang (2014)
Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.
Marina G. Damiano (2013)
CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma.
L. Wang (2012)
GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit.
Yuehui Li (2012)
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
R. van der Meel (2013)
A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Y. Ding (2012)
Choline Transport for Phospholipid Synthesis
Vera Michel (2006)
Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development.
Y. Li (2008)
Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
L. Shi (2016)
Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
A. Kiss (1997)
Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fanfan Fu (2014)
Sorafenib in advanced hepatocellular carcinoma.
G. Spinzi (2008)
Renal clearance of quantum dots
H. Choi (2007)
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.
M. Capurro (2003)
Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics
Rachel E Airley (2007)
131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.
Q. He (2013)
The LDL receptor.
J. Goldstein (2009)
Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study
Y. Chun (2014)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
Molecular and biological properties of the vascular endothelial growth factor family of proteins.
N. Ferrara (1992)
Tissue-penetrating delivery of compounds and nanoparticles into tumors.
K. Sugahara (2009)
In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy.
Cui-Yun Yu (2014)
Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma.
H. Liu (2014)
Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma
H. Reynaert (2004)
Galactosylated polymeric carriers for liver targeting of sorafenib.
E. Craparo (2014)
Prostaglandin E2 stimulates beta1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/ NF-kappaB pathway. Sci Rep
X Bai (2014)
Yuning Hong (2011)
Galactosylated poly(2-(2-aminoethyoxy)ethoxy)phosphazene/DNA complex nanoparticles: in vitro and in vivo evaluation for gene delivery.
Y. Yang (2010)
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
C. Jin (2010)
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
Hamza Chettouh (2013)
Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives
M. Lesurtel (2007)
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
H. Maeda (2001)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T. Takayama (2000)
Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
Q. Ye (2003)
Hepatocellular carcinoma--cause, treatment and metastasis.
Z. Tang (2001)
The Gerbich blood group system: a review.
P. Walker (2010)
Liver Cancer Targeting of Doxorubicin with Reduced Distribution to the Heart Using Hematoporphyrin-Modified Albumin Nanoparticles in Rats
J. Chang (2011)
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems.
L. M. Kaminskas (2012)
Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells.
Hsiang-Fa Liang (2006)
Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody.
Geng Kou (2007)
Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
R. Yang (2011)
Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
K. Wang (2016)
Microvascular permeability of normal and neoplastic tissues.
L. E. Gerlowski (1986)
Sorting and recycling of cell surface receptors and endocytosed ligands: The asialoglycoprotein and transferrin receptors
A. Ciechanover (1983)
Tumor Targeting via Integrin Ligands
U. K. Marelli (2013)
Plasmid pORFhTRAIL and doxorubicin co-delivery targeting to tumor using peptideconjugated polyamidoamine dendrimer
L Han (2011)
Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.
Long-yun Ye (2016)
Beyond chemotherapy: systemic treatment options for hepatocellular carcinoma
Zheng Topp (2013)
High density lipoprotein complexes as delivery vehicles for anticancer drugs.
A. Lacko (2002)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang (2006)
Differential expression of laminin receptors in human hepatocellular carcinoma
I. Ozaki (1998)
Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer.
Takahiro Ishiguro (2008)
Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Yanling Song (2013)
Human hepatic lectin. Physiochemical properties and specificity.
J. Baenziger (1980)
Somatostatin analogs for diagnosis and treatment of cancer.
G. Weckbecker (1993)
Design and synthesis of dual-ligand modified chitosan as a liver targeting vector
Houxiang Chen (2011)
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome
H. Wang (2007)
Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.
Chittima Managit (2005)
CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells
Rong Zhu (2015)
Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
Devaraja Rajasekaran (2015)
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
Wendian Zhang (2015)
Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma.
Bao-guang Hu (2014)
Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody.
Bohua Li (2007)
Immunotherapy of HCC.
T. Greten (2008)
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung (2012)
FGF Receptor-Mediated Gene Delivery Using Ligands Coupled to PEI-β-CyD
Yiping Hu (2012)
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers
C. Tros de Ilarduya (2013)
Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer.
Liang Han (2011)
Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Yinan Zhong (2014)
A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells.
Benoit Frisch (2004)
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
N. Bertrand (2014)
Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo.
S. Zitzmann (2002)
Insight into nanoparticle cellular uptake and intracellular targeting.
Basit Yameen (2014)
Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
Qiao-ling Zhu (2014)
Ligand-based targeted therapy for hepatocellular carcinoma
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)
The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.
Zhenshu Zhu (2011)
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells.
K. Nakano (2009)
Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragments
Jie Gao (2008)
Role of tumor vascular architecture in drug delivery.
A. Narang (2011)
Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks.
Z. Li (2012)
Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications
K. Berg (2005)
Heat-Labile Enterotoxin: Beyond GM1 Binding
Benjamin Mudrak (2010)
CD44 IS EXPRESSED IN HEPATOCELLULAR CARCINOMAS SHOWING VASCULAR INVASION
J. Mathew (1996)
Folic acid: nutritional biochemistry, molecular biology, and role in disease processes.
M. Lucock (2000)
BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis
S. Wilhelm (2004)
Amphiphilic block copolymers for drug delivery.
M. Adams (2003)
Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model
F. Rosso (2013)
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
J. Llovet (2012)
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
Immunotherapy of HCC. Rev Recent Clin Trials
Tf Greten (2008)
Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
A. D’souza (2015)
pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.
Daishun Ling (2014)
iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
Xiao-li Mao (2015)
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide.
S. Oh (2009)
Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells).
C. Senthil Kumar (2015)
Management of hepatocellular carcinoma: An update
J. Bruix (2011)
Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
D. Zhu (2016)
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Stephen Quan (2015)
Biotin-decorated fluorescent silica nanoparticles with aggregation-induced emission characteristics: fabrication, cytotoxicity and biological applications.
M. Li (2013)
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.
K. Uka (2007)
iRGD decorated lipidpolymer hybrid nanoparticles for targeted codelivery of doxorubicin and sorafenib to enhance antihepatocellular carcinoma efficacy
J Zhang (2016)
Glucose Transporter Isoforms GLUT1 and GLUT3 Transport Dehydroascorbic Acid*
S. Rumsey (1997)
Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation.
Xibo Ma (2016)
Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma.
G. L. Malarvizhi (2014)
The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.
Jianxin Jiang (2015)
Folate-mediated targeting: from diagnostics to drug and gene delivery.
C. P. Leamon (2001)
Mechanisms of angiogenesis and arteriogenesis
P. Carmeliet (2000)
Asialoglycoprotein receptormediated gene delivery to hepatocytes using galactosylated polymers. Biomacromolecules
B Thapa (2015)
Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
Zhigui Su (2011)
Fibroblast growth factors are required for efficient tumor angiogenesis.
A. Compagni (2000)
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator–activated receptor γ agonists in colon cancer cells
Sudhakar Chintharlapalli (2007)
Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells.
X. Zhang (2012)
Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
B. Xiao (2015)
Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Yinan Zhong (2013)
Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system.
K. Na (2003)
Expression of Serotonin Receptors in Human Hepatocellular Cancer
C. Soll (2012)
Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
L. Zhao (2014)
Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting.
A. Mitra (2006)
Efficacy, Safety and Anticancer Activity of Protein Nanoparticle-Based Delivery of Doxorubicin through Intravenous Administration in Rats
Kishore Golla (2012)
Folate-functionalized polymeric micelles based on biodegradable PEG-PDLLA as a hepatic carcinoma-targeting delivery system.
Chuanqiang Niu (2011)
Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
E. J. Oh (2010)
Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.
Shuyi Chen (2010)
cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy.
J. Shen (2013)
Somatostatin and its receptor family. Front Neuroendocrinol
Y C Patel (1999)
Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.
Forrest M Kievit (2011)
Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.
Osama A Alsaied (2014)
Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Yubo Guo (2015)
Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway
Xiaoming Bai (2014)
An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy.
M. Liu (2012)
A repeatable assembling and disassembling electrochemical aptamer cytosensor for ultrasensitive and highly selective detection of human liver cancer cells.
Duanping Sun (2015)
Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy.
F. Wang (2016)
Structuredependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator–activated receptor γ agonists in colon cancer cells
S Chintharlapalli (2007)
Polymeric conjugates of mono- and bi-cyclic αvβ3 binding peptides for tumor targeting
A. Mitra (2006)
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins.
I. Wood (2003)
Selfassembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system
K Na (2003)
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
K. Choi (2011)
Overexpression of retinoic acid receptor alpha in hepatocellular carcinoma.
K. Sano (2003)
Angiogenesis and hepatocellular carcinoma.
D. Semela (2004)
Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models
Y. Zhang (2014)
Liver Sinusoidal Endothelial Fenestrations in Caveolin‐1 Knockout Mice
A. Warren (2010)
Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro.
S. Hardy (1988)
HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea.
D. Del Rio (2004)
Decreased PCSK9 expression in human hepatocellular carcinoma
M. Bhat (2015)
Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
L. Zhang (2013)
Evidence for receptor-mediated hepatic uptake of pullulan in rats.
Y. Kaneo (2001)
RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.
F. Danhier (2012)
This paper is referenced by
Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
Q. Zheng (2020)
Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
Zhiman Bai (2019)
Advanced Nanotechnology Leading the Way to Multimodal Imaging-Guided Precision Surgical Therapy.
C. Wang (2019)
Bioinformatics Predictions, Expression, Purification and Structural Analysis of the PE38KDEL-scfv Immunotoxin Against EPHA2 Receptor
E. Rezaie (2019)
Surface decoration of selenium nanoparticles with curcumin induced HepG2 cell apoptosis through ROS mediated p53 and AKT signaling pathways
M. Guo (2017)
Natural plant-derived polygalacturonic acid-oleanolic acid assemblies as oral-delivered nanomedicine for insulin resistance treatment
Yuanjin Zhang (2020)
Comparative study of two poly(amino acid)-based photosensitizer-delivery systems for photodynamic therapy.
Y. Bao (2020)
Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
V. Kumar (2020)
Retinal Photoreceptors Targeting SA-g-AA Coated Multilamellar Liposomes Carrier System for Cytotoxicity and Cellular Uptake Evaluation.
Anishiya Chella Daisy E R (2020)
Preparation of a dual cored hepatoma-specific star glycopolymer nanogel via arm-first ATRP approach
Shaofeng Lou (2017)
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Samrat Chakraborty (2020)
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
L. Baboci (2020)
Recognition Sites for Cancer-Targeting Durg Delivery Systems.
Siyu Guan (2019)
Asialoglycoprotein Receptor and Targeting Strategies
S. Das (2019)
One-Step Formulation of Targeted Aggregation-Induced Emission Dots for Image-Guided Photodynamic Therapy of Cholangiocarcinoma.
Min Li (2017)
Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease
D. Uchida (2018)
Application of photodynamic therapy for liver malignancies.
Heng Zou (2020)
AIE-based cancer theranostics
M. Gao (2020)
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
N. Iturrioz-Rodríguez (2019)
Modulating the site-specific oral delivery of sorafenib using sugar-grafted nanoparticles for hepatocellular carcinoma treatment.
Lakshmi Tunki (2019)
Chemotherapy for hepatocellular carcinoma: The present and the future
Marco Le Grazie (2017)
Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
Y. Zhang (2019)
Recent advances of nanomedicines for liver cancer therapy.
Xiaoqin Chi (2020)
Design, synthesis, and characterization of glycyrrhetinic acid-mediated multifunctional liver-targeting polymeric carrier materials
Qingxia Guan (2020)
Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression
Zirong Pan (2018)
Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
G. Singh (2020)
DEVELOPMENT OF INNOVATIVE FORMULATIONS BASED ON POLYSACCHARIDES FOR TUMOR TREATMENT
Simona Giarra (2017)
Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice
Aditi Varshney (2018)
A Comparative Investigation of the Ability of Various Aptamer-Functionalized Drug Nanocarriers to Induce Selective Apoptosis in Neoplastic Hepatocytes: In Vitro and In Vivo Outcome
Samrat Chakraborty (2020)
Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma
Y. Gao (2019)
VTIQ evaluates antitumor effects of NET-1 siRNA by UTMD in HCC xenograft models
Xitian Liang (2018)
Advances in thermosensitive polymer-grafted platforms for biomedical applications.
P. Le (2018)See more